Human carboxylesterases and their role in xenobiotic and endobiotic metabolism

Journal of Biochemical and Molecular Toxicology

Volumn 21, Issue 4, 2007, Pages 187-196

  Ross, Matthew K ^a   Crow, J Allen ^a  

^a MISSISSIPPI STATE UNIVERSITY   (United States)

Author keywords

Carboxylesterases; Cholesteryl ester hydrolase; Interindividual variation; Organophosphate; Pyrethroids

Indexed keywords

BIORESMETHRIN; CARBOXYLESTERASE; CHOLESTEROL ESTER; INSECTICIDE; PROTEOME; PYRETHROID; TRIACYLGLYCEROL; XENOBIOTIC AGENT; ISOENZYME; ORGANOPHOSPHATE; RECOMBINANT PROTEIN;

CATALYSIS; CONFERENCE PAPER; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME POLYMORPHISM; ENZYME SUBSTRATE COMPLEX; HUMAN; HYDROLYSIS; INTESTINE CELL; LIVER MICROSOME METABOLISM; MULTIGENE FAMILY; NONHUMAN; POLLUTANT; PREDICTION; PROTEIN EXPRESSION; SPECIES DIFFERENCE; XENOBIOTIC METABOLISM; BIOLOGICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; ENZYME SPECIFICITY; ENZYMOLOGY; FORECASTING; GENETICS; LIVER; LIVER MICROSOME; METABOLISM; REVIEW;

CARBOXYLIC ESTER HYDROLASES; CHOLESTEROL ESTERS; FORECASTING; HUMANS; ISOENZYMES; LIVER; MICROSOMES, LIVER; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; PHOSPHORIC ACID ESTERS; PYRETHRINS; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY; TRIGLYCERIDES;

EID: 36049039119     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.20178     Document Type: Conference Paper

References (57)

1. Liebler DC, Guengerich FP. Elucidating mechanisms of drug-induced toxicity. Nat Rev Drug Discov 2005;4:410-420.
2. Godin SJ, Scollon EJ, Hughes MF, Potter PM, DeVito MJ, Ross MK. Species differences in the in vitro metabolism of deltamethrin and esfenvalerate: Differential oxidative and hydrolytic metabolism by humans and rats. Drug Metab Dispos 2006;34:1764-1771.
3. Cygler M, Schrag JD, Sussman JL, Harel M, Silman I, Gentry MK, Doctor BP Relationship between sequence conservation and three-dimensional structure in a large family of esterases, lipases, and related proteins. Protein Sci 1993;2:366-382.
4. Satoh T, Hosokawa M. The mammalian carboxylesterases: From molecules to functions. Annu Rev Pharmacol Toxicol 1998;38:257-288.
5. Bencharit S, Morton CL, Hyatt JL, Kuhn P, Danks MK, Potter PM, Redinbo MR. Crystal structure of human carboxy lesterase 1 complexed with the Alzheimer's drug tacrine. From binding promiscuity to selective inhibition. Chem Biol 2003;10:341-349.
6. Hedstrom L. Serine protease mechanism and specificity. Chem Rev 2002;102:4501-4524.
7. Godin SJ, Crow JA, Scollon EJ, Hughes MF, DeVito MJ, Ross MK. Identification of rat and human cytochrome P450s and a rat serum esterase which metabolize deltamethrin and esfenvalerate. 2007; Drug Metab Dispos. Manuscript submitted for publication (in press).
8. Lehner R, Cui Z, Vance DE. Subcellular localization, developmental expression and characterization of a liver triacylglycerol hydrolase. Biochem J 1999;338:761-768.
9. Hosokawa M, Furihata T, Yaginuma Y, Yamamoto N, Koyano N, Fujii A, Nagahara Y, Satoh T, Chiba K. Genomic structure and transcriptional regulation of the rat, mouse, and human carboxylesterase genes. Drug Metab Rev 2007;39:1-15.
10. Satoh T, Taylor P, Bosron WF, Sanghani SP, Hosokawa M, La Du BN. Current progress on esterases: From molecular structure to function. Drug Metab Dispos 2002;30:488-493.
11. Schwer H, Langmann T, Daig R, Becker A, Aslanidis C, Schmitz G. Molecular cloning and characterization of a novel putative carboxylesterase, present in human intestine and liver. Biochem Biophys Res Commun 1997;233:117-120.
12. Crow JA, Borazjani A, Potter PM, Ross MK. Hydrolysis of pyrethroids by human and rat tissues: Examination of intestinal, liver and serum carboxylesterases. Toxicol Appl Pharmacol 2007;221:1-12.
13. Imai T. Human carboxylesterase isozymes: Catalytic properties and rational drug design. Drug Metab Pharmacokinet 2006;21:173-185.
14. Robbi M, Beaufay H. The COOH terminus of several liver carboxylesterases targets these enzymes to the lumen of the endoplasmic reticulum. J Biol Chem 1991;266:20498-20503.
15. Gonzalez CF, Proudfoot M, Brown G, Korniyenko Y, Mori H, Savchenko AV, Yakunin AF. Molecular basis of formaldehyde detoxification. Characterization of two S-formylglutathione hydrolases from Escherichia coli, FrmB and YeiG. J Biol Chem 2006;281:14514-14522.
16. Li B, Sedlacek M, Manoharan I, Boopathy R, Duysen EG, Masson P, Lockridge O. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma. Biochem Pharmacol 2005;70:1673-1684.
17. Potter PM, Wadkins RM. Carboxylesterases - detoxifying enzymes and targets for drug therapy. Curr Med Chem 2006;13:1045-1054.
18. Hodgson E, Levi PE. Pesticides: An important but underused model for the environmental health sciences. Environ Health Perspect 1996;104(Suppl. 1):97-106.
19. Takken W. Do insecticide-treated bed nets have an effect on malaria vectors? Trop Med Int Health 2002;7:1022-1030.
20. Gaughan LC, Engel JL, Casida JE. Pesticide interactions: Effects of organophophorus pesticides on the metabolism, toxicity, and persistence of selected pyrethroid insecticides. Pest Biochem Physiol 1980;14:81-85.
21. Soderlund DM, Casida JE. Effects of pyrethroid structure on rates of hydrolysis and oxidation by mouse liver microsomal enzymes. Pest Biochem Physiol 1977;7:391-401.
22. Choi J, Hodgson E, Rose RL. In vitro human metabolism of permethrin: The role of human alcohol and aldehyde dehydrogenases. Pest Biochem Physiol 2002;73:117-128.
23. Anand SS, Bruckner JV, Haines WT, Muralidhara S, Fisher JW, Padilla S. Characterization of deltamethrin metabolism by rat plasma and liver microsomes. Toxicol Appl Pharmacol 2006;212:156-166.
24. Ross MK, Borazjani A, Edwards CC, Potter PM. Hydrolytic metabolism of pyrethroids by human and other mammalian carboxylesterases. Biochem Pharmacol 2006;71:657-669.
25. Evans MJ, Cravatt BF. Mechanism-based profiling of enzyme families. Chem Rev 2006;106:3279-3301.
26. Saghatelian A, Cravatt BF. Assignment of protein function in the postgenomic era. Nat Chem Biol 2005;1:130-142.
27. Barglow KT, Cravatt BF. Discovering disease-associated enzymes by proteome reactivity profiling. Chem Biol 2004;11:1523-1531.
28. Jessani N, Liu Y, Humphrey M, Cravatt BF. Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness. Proc Natl Acad Sci USA 2002;99:10335-10340.
29. Liu Y, Patricelli MP, Cravatt BF. Activity-based protein profiling: The serine hydrolases. Proc Natl Acad Sci USA. 1999;96:14694-14699.
30. Kidd D, Liu Y, Cravatt BF. Profiling serine hydrolase activities in complex proteomes. Biochemistry 2001;40:4005-4015.
31. Nomura DK, Durkin KA, Chiang KP, Quistad GB, Cravatt BF, Casida JE. Serine Hydrolase KIAA1363: Toxicological and structural features with emphasis on organophosphate interactions. Chem Res Toxicol 2006;19:1142-1150.
32. Dolinsky VW, Gilham D, Alam M, Vance DE, Lehner R. Triacylglycerol hydrolase: Role in intracellular lipid metabolism. Cell Mol Life Sci 2004;61:1633-1651.
33. Zhao B, Song J, Clair R St, Ghosh S. Stable over-expression of human macrophage cholesteryl ester hydrolase (CEH) results in enhanced free cholesterol efflux from human THP1-macrophages. Am J Physiol Cell Physiol 2006;292:C405-C412.
34. Wenk MR. The emerging field of lipidomics. Nat Rev Drug Discov 2005;4:594-610.
35. Watson AD. Lipidomics: A global approach to lipid analysis in biological systems. J Lipid Res 2006;47:2101-2111.
36. Fleming I, Busse R. Endothelium-derived epoxyeicosatrienoic acids and vascular function. Hypertension 2006;47:629-633.
37. Osuga J, Ishibashi S, Oka T, Yagyu H, Tozawa R, Fujimoto A, Shionoiri F, Yahagi N, Kraemer FB, Tsutsumi O, Yamada N. Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proc Natl Acad Sci USA 2000;97:787-792.
38. Haemmerle G, Lass A, Zimmermann R, Gorkiewicz G, Meyer C, Rozman J, Heldmaier G, Maier R, Theussl C, Eder S, Kratky D, Wagner EF, Klingenspor M, Hoefler G, Zechner R. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 2006;312:734-737.
39. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Nat Acad Sci USA 1979;76:333-337.
40. Fogelman AM, Shechte RL, Seager J, Hokom M, Child JS, Edwards PA. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc Natl Acad Sci USA 1980;77:2214-2218.
41. Lewis GF, Rader DJ. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 2005;96:1221-1232.
42. Ghosh S, Clair RW St, Rudel LL. Mobilization of cytoplasmic CE droplets by overexpression of human macrophage cholesteryl ester hydrolase. J Lipid Res 2003;44:1833-1840.
43. Small CA, Goodacre JA, Yeaman SJ. Hormone-sensitive lipase is responsible for the neutral cholesterol ester hydrolase activity in macrophages. FEBS Lett 1989;247:205-208.
44. Ghosh S. Cholesteryl ester hydrolase in human monocyte/macrophage: Cloning, sequencing and expression of full length cDNA. Physiol Genomics 2000;2:1-8.
45. Redinbo MR, Potter PM. Mammalian carboxylesterases: From drug targets to protein therapeutics. Drug Discov Today 2005;10:313-325.
46. Okazaki H, Osuga J, Tsukamoto K, Isoo N, Kitamine T, Tamura Y, Tomita S, Sekiya M, Yahagi N, Iizuka Y, Ohashi K, Harada K, Gotoda T, Shimano H, Kimura S, Nagai R, Yamada N, Ishibashi S. Elimination of cholesterol ester from macrophage foam cells by adenovirus-mediated gene transfer of hormone-sensitive lipase. J Biol Chem 2002;277:31893-31899.
47. Contreras JA, Lasuncion MA. Essential differences in cholesteryl ester metabolism between human monocyte-derived and J774 macrophages. Evidence against the presence of hormone-sensitive lipase in human macrophages. Arterioscler Thromb 1994;14:443-452.
48. Contreras JA. Hormone-sensitive lipase is not required for cholesteryl ester hydrolysis in macrophages. Biochem Biophys Res Commun 2002;292:900-903.
49. Zhao B, Natarajan R, Ghosh S. Human liver cholesteryl ester hydrolase: Cloning, molecular characterization, and role in cellular cholesterol homeostasis. Physiol Genomics 2005;23:304-310.
50. Graham A, Angell AD, Jepson CA, Yeaman SJ, Hassall, DG. Impaired mobilisation of cholesterol from stored cholesteryl esters in human (THP-1) macrophages. Atherosclerosis 1996;120:135-145.
51. Zhao B, Fisher BJ, Clair RW St, Rudel LL, Ghosh S. Redistribution of macrophage cholesteryl ester hydrolase from cytoplasm to lipid droplets upon lipid loading. J Lipid Res 2005;46:2114-2121.
52. Morton CL, Potter PM. Comparison of Escherichia coli, Saccharomyces cerevisiae, Pichia pastoris, Spodoptera frugiperda, and COS7 cells for recombinant gene expression. Application to a rabbit liver carboxylesterase. Mol Biotechnol 2000;16:193-202.
53. Nishi K, Huang H, Kamita SG, Kim IH, Morisseau C, Hammock BD. Characterization of pyrethroid hydrolysis by the human liver carboxylesterases hCE-1 and hCE-2. Arch Biochem Biophys 2006;445:115-123.
54. Wadkins RM, Hyatt JL, Wei X, Yoon KJ, Wierdl M, Edwards CC, Morton CL, Obenauer JC, Damodaran K, Beroza P, Danks MK, Potter PM. Identification and characterization of novel benzil (diphenylethane-1,2-dione)analogues as inhibitors of mammalian carboxylesterases. J Med Chem 2005;48:2906-2915.
55. Hyatt JL, Stacy V, Wadkins RM, Yoon KJ, Wierdl M, Edwards CC, Zeller M, Hunter AD, Danks MK, Crundwell G, Potter PM. Inhibition of carboxylesterases by benzil (diphenylethane-1,2-dione) and heterocyclic analogues is dependent upon the aromaticity of the ring and the flexibility of the dione moiety. J Med Chem 2005;48:5543-5550.
56. Wheelock CE, Wheelock AM, Zhang R, Stok JE, Morisseau C, Le Valley SE, Green CE, Hammock BD. Evaluation of alpha-cyanoesters as fluorescent substrates for examining interindividual variation in general and pyrethroid-selective esterases in human liver microsomes. Anal Biochem 2003;315:208-222.
57. Hui DY, Howies PN. Carboxyl ester lipase: Structure-function relationship and physiological role in lipoprotein metabolism and atherosclerosis. J Lipid Res 2002;43:2017-2030.